MicroRNAs in pancreatic malignancy: Progress and promises-Reference-Cited by-同舟云学术

MicroRNAs in pancreatic malignancy: Progress and promises

Published:2014-06 Issue:2 Volume:347 Page:167-174
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Srivastava Sanjeev K.,Arora Sumit,Singh Seema,Bhardwaj Arun,Averett Courey,Singh Ajay P.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference90 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J. Clin.,2013

2. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB- and hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4;Arora;J. Biol. Chem.,2013

3. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database;Sener;J. Am. Coll. Surg.,1999

4. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry;Kuramitsu;Anticancer Res.,2010

5. MicroRNAs as potential clinical biomarkers: emerging approaches for their detection;Srivastava;Biotech. Histochem.,2013

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA electrochemical biosensors for pancreatic cancer;Clinica Chimica Acta;2023-08

2. The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?;International Journal of Molecular Sciences;2023-06-16

3. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma;International Journal of Molecular Sciences;2023-04-13

4. Investigating the interference of single nucleotide polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: An in silico approach;Gene;2022-04

5. Syntenin Regulated by miR-216b Promotes Cancer Progression in Pancreatic Cancer;Frontiers in Oncology;2022-01-28